下記論文が「Blood Advances」誌に掲載されました。
Novel anti-myeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
T. Harada, H. Ohguchi, A. Oda, M. Nakao, J. Teramachi, M. Hiasa, R. Sumitani, M. Oura, K. Sogabe, T. Maruhashi, M. Takahashi, S. Fujii, S. Nakamura, H. Miki, K. Kagawa, S. Ozaki, S. Sano, T. Hideshima, and M. Abe,
Blood Advances, in press.
https://doi.org/10.1182/bloodadvances.2022007155
Read Blood Advances at
https://ashpublications.org/bloodadvances/first-edition
